{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-048392","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2023-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.798429+00:00","generated_at":"2026-06-10T16:25:00.289189+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Aptevo Therapeutics receives Nasdaq bid price deficiency notice; delisting risk","bullets":["Received Nasdaq letter on Sept 13, 2023; bid price below $1.00 for 30 consecutive days.","Must regain compliance by March 11, 2024; bid price must close at $1.00+ for 10 consecutive days.","If not compliant, may seek 180-day extension by meeting other listing standards and effecting reverse stock split.","Failure to regain compliance may result in delisting; company evaluating options to cure deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-048392","json":"https://secwatch.observer/filing/0000950170-23-048392.json","markdown":"https://secwatch.observer/filing/0000950170-23-048392.md","text":"https://secwatch.observer/filing/0000950170-23-048392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017023048392/0000950170-23-048392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017023048392/apvo-20230913.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T16:25:00.289189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"32b59e5973c3d317aa1a78bec04e46138dc13194","claim":"Aptevo Therapeutics Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"September 13, 2023, Aptevo Therapeutics Inc. (the “Company”) received a letter from the staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until March 11, 2024 (the “Compliance Date”), to regain compliance with","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017023048392/0000950170-23-048392-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}